Fluor's Q2 Earnings Surge Signals Core Recovery, Stabilizing Buyback Backdrop

What happened

Fluor reported second-quarter 2026 revenue of $4.3 billion, a 9% increase year-over-year, with adjusted EBITDA nearly doubling to $149 million from $96 million and adjusted EPS rising to $0.91 from $0.43. The results exceeded the tepid expectations baked into the DeepValue base case, offering concrete evidence that project execution is improving and legacy cost pressures are easing. While the NuScale monetization and share repurchase plan remain central to the equity story, these operating gains suggest the core business can generate cash internally, reducing reliance on asset sales. Still, the quarterly numbers do not address the Energy Solutions backlog contraction or the upcoming Santos appeal, meaning the stock is not yet out of the woods. Overall, the print validates the bull scenario’s premise that operating momentum can complement the buyback catalyst, raising the probability of reaching the $55 base-case implied value.

Implication

Fluor’s Q2 beat strengthens the investment thesis by demonstrating that the company can generate improved earnings even before the full NuScale exit, which provides a buffer against potential buyback slowdowns. The sharp rebound in adjusted EBITDA suggests that management’s cost controls and project discipline are taking hold, addressing a key concern from the DeepValue report that core cash conversion was weak. With the NuScale monetization still on track and a large buyback authorization in place, these results give investors greater confidence that capital returns can be funded through both asset sales and organic cash flow. However, the Energy Solutions backlog remains depressed, and the Santos appeal still looms, so the thesis is not fully de-risked. Investors should use any post-earnings pullbacks as opportunities to add, as the improving fundamentals tilt the risk-reward favorably toward the $55 base case.

Thesis delta

The Q2 results materially upgrade the operating outlook, shifting the thesis from a pure monetization-and-buyback catalyst play to one supported by genuine earnings recovery. This reduces the bear-case probability and raises confidence that 2026 EBITDA can land in the upper half of the $525M–$585M guidance range. The stronger cash flow potential also lessens the dependency on NuScale proceeds to sustain the buyback pace, making the capital return story more durable.